« Back
First Quarter Results for Fiscal 2020
Feb 04, 2020
Record Quarterly Revenue of
Record Quarterly Backlog of
Raises Fiscal 2020 Normalized Free Cash Flow Outlook to
First Quarter Fiscal 2020 Highlights
- Revenue of
$1,042 million , above the midpoint of the$1,015-$1,055 million guidance range, adjusting for a positive impact from foreign currency movements of approximately$4 million compared to our guidance assumptions - GAAP diluted EPS of
$0.85 , above the midpoint of the$0.79-$0.87 guidance range - Non-GAAP diluted EPS of
$1.06 , above the midpoint of the$1.02-$1.08 guidance range - GAAP operating income of
$144 million ; GAAP operating margin of 13.8% - Non-GAAP operating income of
$178 million ; non-GAAP operating margin of 17.1% - Quarterly free cash flow of
$105 million , comprised of cash flow from operations of$164 million , less$59 million in net capital expenditures and other; normalized free cash flow of$121 million (1) - Twelve-month backlog of
$3.52 billion , up$30 million sequentially and up 4.5% as compared to last year’s first fiscal quarter - The board of directors approved a quarterly cash dividend at the new increased rate of
$0.3275 per share, as approved at theJanuary 2020 annual general meeting of shareholders, to be paid onApril 24, 2020
“We are pleased to report a solid start to the fiscal year, with record revenue driven by sequential growth in
Sheffer continued, “During Q1, we secured pivotal new wins that extend our core market leadership in key domains such as digital modernization and customer experience. Earlier in the quarter, we announced that Vodafone Germany had selected
Sheffer concluded, “Turning to the outlook, we expect revenue growth to accelerate in the fiscal second half as new customer activity ramps-up. Our visibility is supported by record 12-month backlog of
Revenue
Revenue for the first fiscal quarter ended
Net Income and Earnings Per Share
The Company's GAAP net income for the first quarter of fiscal 2020 was
For further details of reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.
Returning Cash to Shareholders
- Quarterly Cash Dividend Program: On
February 4, 2020 , the Board approved the Company’s next quarterly cash dividend payment of$0.3275 per share and setMarch 31, 2020 as the record date for determining the shareholders entitled to receive the dividend, which will be payable onApril 24, 2020 . - Share Repurchase Activity: Repurchased
$90 million of ordinary shares during the first quarter of fiscal 2020.
Twelve-month Backlog
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was
Second Quarter Fiscal 2020 Outlook
- Revenue of approximately
$1,035-$1,075 million , assuming approximately$2 million sequential positive impact from foreign currency fluctuations as compared to the first quarter of fiscal 2020 - GAAP diluted EPS of approximately
$0.82-$0.90 . - Non-GAAP diluted EPS of approximately
$1.03-$1.09 , excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately$0.06-$0.08 per share of equity-based compensation expense, net of related tax effects
Full Year Fiscal 2020 Outlook
- Expects revenue growth of 2.5%-5.5% year-over-year on a reported basis as compared with 1.5%-5.5% year-over-year previously
- Expects revenue growth of 2.5%-5.5% year-over-year on a constant currency basis as compared with 2.0%-6.0% year-over-year previously
- Full year fiscal 2020 revenue guidance incorporates just over 1% of growth from the acquisition of
TTS Wireless , and an immaterial impact from foreign currency fluctuations as compared with a negative impact of about 0.5% year-over-year previously - Reiterates GAAP diluted earnings per share growth of roughly 5.0%-12.0% year-over-year
- Reiterates non-GAAP diluted earnings per share growth of roughly 3.0%-7.0% year-over-year, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately
$0.24-$0.30 per share of equity-based compensation expense, net of related tax effects. - Expects free cash flow of approximately
$400 million , comprised of cash flow from operations, less net capital expenditures and other, as compared with$350 million previously - Expects normalized free cash flow of approximately
$500 million as compared with$480 million previously; normalized free cash flow excludes capital expenditure of up to$90 million related to the new campus development inIsrael , as compared with capital expenditure of up to$120 million previously, and other items
Our second fiscal quarter 2020 and full year fiscal 2020 outlook takes into consideration the Company’s expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However,
Conference Call Details
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:
- amortization of purchased intangible assets and other acquisition-related costs;
- changes in certain acquisition-related liabilities measured at fair value;
- non-recurring and unusual charges;
- equity-based compensation expense;
- other; and
- tax effects related to the above.
Free cash flow equals cash generated by operating activities less net capital expenditures and other, and normalized free cash flow is adjusted to exclude net capital expenditures related to the new campus development, payments for previously expensed restructuring charges, payments for legal dispute settlement, and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, non-recurring and unusual charges, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of
Supporting Resources
- Keep up with
Amdocs news by visiting the Company’s website - Subscribe to Amdocs’ RSS Feed and follow us on Twitter,
Facebook , LinkedIn andYouTube
About
For more information, visit
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market.
Contact:
Head of Investor Relations
314-212-8328
E-mail: dox_info@amdocs.com
______________________________________
(1) Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding).
(2) Total expected shareholder return includes non-GAAP EPS growth of 3% to 7% in fiscal 2020 plus dividend yield of ~1.8% (assumes quarterly dividend rate of
AMDOCS LIMITED | ||||||||
Consolidated Statements of Income (In thousands, except per share data) |
||||||||
Three months ended | ||||||||
December 31, | ||||||||
2019 | 2018 | |||||||
Revenue | $ | 1,041,957 | $ | 1,012,055 | ||||
Operating expenses: | ||||||||
Cost of revenue | 686,312 | 662,568 | ||||||
Research and development | 67,311 | 68,686 | ||||||
Selling, general and administrative | 123,467 | 121,860 | ||||||
Amortization of purchased intangible assets and other | 21,290 | 25,844 | ||||||
898,380 | 878,958 | |||||||
Operating income | 143,577 | 133,097 | ||||||
Interest and other (expense) income, net | (352 | ) | 1,522 | |||||
Income before income taxes | 143,225 | 134,619 | ||||||
Income taxes | 27,293 | 32,927 | ||||||
Net income | $ | 115,932 | $ | 101,692 | ||||
Basic earnings per share | $ | 0.86 | $ | 0.73 | ||||
Diluted earnings per share | $ | 0.85 | $ | 0.72 | ||||
Basic weighted average number of shares outstanding | 134,596 | 139,639 | ||||||
Diluted weighted average number of shares outstanding | 135,617 | 140,511 | ||||||
Cash dividends declared per share | $ | 0.285 | $ | 0.250 | ||||
AMDOCS LIMITED Selected Financial Metrics (In thousands, except per share data) |
||||||||
Three months ended | ||||||||
December 31, | ||||||||
2019 | 2018 | |||||||
Revenue | $ | 1,041,957 | $ | 1,012,055 | ||||
Non-GAAP operating income | 177,940 | 174,849 | ||||||
Non-GAAP net income | 144,155 | 137,818 | ||||||
Non-GAAP diluted earnings per share | $ | 1.06 | $ | 0.98 | ||||
Diluted weighted average number of shares outstanding | 135,617 | 140,511 | ||||||
Free Cash Flows and Normalized Free Cash Flow (In thousands) |
||||||||
Three months ended | ||||||||
December 31, | ||||||||
2019 | 2018 | |||||||
Net Cash Provided by Operating Activities | $ | 163,908 | $ | 109,650 | ||||
Purchase of property and equipment, net (*) | (58,535 | ) | (37,278 | ) | ||||
Free Cash Flow | 105,373 | 72,372 | ||||||
Payments for legal dispute settlement | - | 55,000 | ||||||
Payments for previously expensed restructuring charges | 1,516 | 6,625 | ||||||
Net capital expenditures related to the new campus development | 13,937 | 2,054 | ||||||
Normalized Free Cash Flow | 120,826 | 136,051 | ||||||
(*) The amounts under "Purchase of property and equipment, net”, include proceed from sale of property and equipment of
AMDOCS LIMITED Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP (In thousands) |
||||||||||||||||
Three months ended December 31, 2019 |
||||||||||||||||
Reconciliation items | ||||||||||||||||
GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in certain acquisitions related liabilities measured at fair value |
Tax effect |
Non-GAAP | |||||||||||
Operating expenses: | ||||||||||||||||
Cost of revenue | $ | 686,312 | $ | - | $ | (5,346 | ) | $ | (2,312 | ) | $ | - | $ | 678,654 | ||
Research and development | 67,311 | - | (803 | ) | - | - | 66,508 | |||||||||
Selling, general and administrative | 123,467 | - | (4,612 | ) | - | - | 118,855 | |||||||||
Amortization of purchased intangible assets and other | 21,290 | (21,290 | ) | - | - | - | - | |||||||||
Total operating expenses | 898,380 | (21,290 | ) | (10,761 | ) | (2,312 | ) | - | 864,017 | |||||||
Operating income | 143,577 | 21,290 | 10,761 | 2,312 | - | 177,940 | ||||||||||
Income taxes | 27,293 | - | - | - | 6,140 | 33,433 | ||||||||||
Net income | $ | 115,932 | $ | 21,290 | $ | 10,761 | $ | 2,312 | $ | (6,140 | ) | $ | 144,155 | |||
|
||||||||||||||||
Three months ended December 31, 2018 |
||||||||||||||||
Reconciliation items | ||||||||||||||||
GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in certain acquisitions related liabilities measured at fair value |
Tax effect |
Non-GAAP |
|||||||||||
Operating expenses: | ||||||||||||||||
Cost of revenue | $ | 662,568 | $ | - | $ | (4,851 | ) | $ | (3,791 | ) | $ | - | $ | 653,926 | ||
Research and development | 68,686 | - | (765 | ) | - | - | 67,921 | |||||||||
Selling, general and administrative | 121,860 | - | (6,501 | ) | - | - | 115,359 | |||||||||
Amortization of purchased intangible assets and other | 25,844 | (25,844 | ) | - | - | - | - | |||||||||
Total operating expenses | 878,958 | (25,844 | ) | (12,117 | ) | (3,791 | ) | - | 837,206 | |||||||
Operating income | 133,097 | 25,844 | 12,117 | 3,791 | - | 174,849 | ||||||||||
Income taxes | 32,927 | - | - | - | 5,626 | 38,553 | ||||||||||
Net income | $ | 101,692 | $ | 25,844 | $ | 12,117 | $ | 3,791 | $ | (5,626 | ) | $ | 137,818 | |||
AMDOCS LIMITED Condensed Consolidated Balance Sheets (In thousands) |
||||||||
As of | ||||||||
December 31, 2019 |
September 30, 2019 |
|||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 485,875 | $ | 471,632 | ||||
Accounts receivable, net, including unbilled of $205,080 and $227,061, respectively | 1,002,264 | 987,858 | ||||||
Prepaid expenses and other current assets | 223,385 | 216,084 | ||||||
Total current assets | 1,711,524 | 1,675,574 | ||||||
Property and equipment, net | 538,709 | 525,314 | ||||||
Lease assets | 280,670 | - | ||||||
Goodwill and other intangible assets, net | 2,645,341 | 2,667,997 | ||||||
Other noncurrent assets | 456,031 | 423,941 | ||||||
Total assets | $ | 5,632,275 | $ | 5,292,826 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable, accruals and other | $ | 1,076,333 | $ | 1,089,748 | ||||
Lease liabilities | 57,752 | - | ||||||
Deferred revenue | 134,401 | 118,182 | ||||||
Total current liabilities | 1,268,486 | 1,207,930 | ||||||
Lease liabilities | 223,664 | - | ||||||
Other noncurrent liabilities | 558,321 | 542,430 | ||||||
Total Amdocs Limited Shareholders’ equity | 3,539,295 | 3,499,957 | ||||||
Noncontrolling interests | 42,509 | 42,509 | ||||||
Total equity | 3,581,804 | 3,542,466 | ||||||
Total liabilities and equity | $ | 5,632,275 | $ | 5,292,826 | ||||
AMDOCS LIMITED Consolidated Statements of Cash Flows (In thousands) |
||||||||
Three months ended December 31, |
||||||||
2019 | 2018 | |||||||
Cash Flow from Operating Activities: | ||||||||
Net income | $ | 115,932 | $ | 101,692 | ||||
Reconciliation of net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 48,999 | 51,477 | ||||||
Equity-based compensation expense | 10,761 | 12,117 | ||||||
Deferred income taxes | 6,359 | (4,505 | ) | |||||
Gain from short-term interest-bearing investments | - | (30 | ) | |||||
Net changes in operating assets and liabilities, net of amounts acquired: | ||||||||
Accounts receivable, net | (34,693 | ) | (26,406 | ) | ||||
Prepaid expenses and other current assets | (10,114 | ) | 20,174 | |||||
Other noncurrent assets | (366 | ) | 2,552 | |||||
Lease assets and liabilities, net | (870 | ) | - | |||||
Accounts payable, accrued expenses and accrued personnel | 9,737 | (50,332 | ) | |||||
Deferred revenue | 12,855 | (11,922 | ) | |||||
Income taxes payable, net | 1,446 | 23,887 | ||||||
Other noncurrent liabilities | 3,862 | (9,054 | ) | |||||
Net cash provided by operating activities | 163,908 | 109,650 | ||||||
Cash Flow from Investing Activities: | ||||||||
Purchase of property and equipment, net (*) | (58,535 | ) | (37,278 | ) | ||||
Proceeds from sale of short-term interest-bearing investments | - | 860 | ||||||
Net cash paid for acquisitions | - | (8,331 | ) | |||||
Other | (2,458 | ) | 857 | |||||
Net cash used in investing activities | (60,993 | ) | (43,892 | ) | ||||
Cash Flow from Financing Activities: | ||||||||
Repurchase of shares | (90,020 | ) | (99,182 | ) | ||||
Proceeds from employee stock options exercised | 41,178 | 8,379 | ||||||
Payments of dividends | (38,413 | ) | (35,046 | ) | ||||
Payment of contingent consideration from a business acquisition | (1,411 | ) | - | |||||
Other | (6 | ) | (35 | ) | ||||
Net cash used in financing activities | (88,672 | ) | (125,884 | ) | ||||
Net increase (decrease) in cash and cash equivalents | 14,243 | (60,126 | ) | |||||
Cash and cash equivalents at beginning of period | 471,632 | 418,783 | ||||||
Cash and cash equivalents at end of period | $ | 485,875 | $ | 358,657 | ||||
(*) The amounts under "Purchase of property and equipment, net”, include proceeds from sale of property and equipment of
AMDOCS LIMITED Supplementary Information (In millions) |
|||||||||||||||
Three months ended | |||||||||||||||
December 31, 2019 |
September 30, 2019 |
June 30, 2019 |
March 31, 2019 |
December 31, 2018 |
|||||||||||
North America | $ | 662.1 | $ | 644.2 | $ | 643.9 | $ | 634.2 | $ | 660.5 | |||||
Europe | 154.7 | 156.1 | 145.5 | 151.0 | 146.1 | ||||||||||
Rest of the World | 225.2 | 230.0 | 235.3 | 234.5 | 205.5 | ||||||||||
Total Revenue | $ | 1,042.0 | $ | 1,030.3 | $ | 1,024.7 | $ | 1,019.7 | $ | 1,012.1 | |||||
Three months ended | |||||||||||||||
December 31, 2019 |
September 30, 2019 |
June 30, 2019 |
March 31, 2019 |
December 31, 2018 |
|||||||||||
Managed Services Revenue | $ | 579.7 | $ | 583.3 | $ | 578.1 | $ | 559.5 | $ | 525.5 | |||||
As of | |||||||||||||||
December 31, 2019 |
September 30, 2019 |
June 30, 2019 |
March 31, 2019 |
December 31, 2018 |
|||||||||||
12-Month Backlog | $ | 3,520 | $ | 3,490 | $ | 3,400 | $ | 3,390 | $ | 3,370 | |||||